Another strong InDesign alternative is VivaDesigner, which comes in both desktop and browser-based flavours and packs in ...

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out ...

Seven meat shops, around 20 temporary vegetable shops, a creche, five illegal carts, and a kabadi (scrap) shop, among others, ...

Pharma marketers enter 2026 asking where DTC fits in the DTP era. That question, which few foresaw 12 months ago, reflects the fast rise of direct-to-patient (DTP) programs. In the last few months ...

This exciting project will engineer light-driven microreactors converting nitrate to ammonia thereby delivering proof-of-principle for a sustainable technology converting a widespread pollutant, ...

Recent technological advances allow us to design and construct entire chromosomes, allowing unprecedented potential for the creation of cellular machines. These synthetic designer de novo chromosomes ...

As affordability, access, and transparency reshape U.S. healthcare, manufacturers are rapidly redefining direct-to-patient drug distribution as a core strategic capability, one that demands fully ...

In this episode, we explore how the consumerization of healthcare has pharma thinking more like retailers. FullSpan Health’s Suzy Jackson joins us to talk about its new digital health division and ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. TL;DR: A wide range of ...

WOODBURY, Minn.--(BUSINESS WIRE)--Patron Points Inc. an industry-leading full stack loyalty and scan data solutions provider dedicated to the convenience industry, announced today its commitment to ...

Abstract: This study aimed to examine the problems experienced by senior students studying at education faculties in the distance Teaching practice (DTP) course, where they participated in practice ...

RFK Jr. stunned the global health world when he said the U.S. would halt funding the group that helps provide vaccines to many low-income countries. The study he cited is seen by others as dubious.